FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 31.96

Change

-1.12 (-3.39)%

Market Cap

N/A

Volume

0.44M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-2.57 (-1.87%)

USD 19.16B
VOT Vanguard Mid-Cap Growth Index ..

-3.92 (-1.44%)

USD 16.53B
IJK iShares S&P Mid-Cap 400 Growth..

-1.27 (-1.36%)

USD 9.61B
XMMO Invesco S&P MidCap Momentum ET..

-2.36 (-1.85%)

USD 4.68B
IVOG Vanguard S&P Mid-Cap 400 Growt..

-1.40 (-1.21%)

USD 1.15B
CWS AdvisorShares Focused Equity E..

-0.13 (-0.19%)

USD 0.18B
ETHO Amplify ETF Trust

-0.44 (-0.72%)

USD 0.18B
IPO Renaissance IPO ETF

-0.78 (-1.68%)

USD 0.16B
BFOR Barron's 400 ETF

-0.84 (-1.10%)

USD 0.16B
PEXL Pacer US Export Leaders ETF

-0.06 (-0.12%)

USD 0.05B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.79% 100% F 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.79% 100% F 89% A-
Trailing 12 Months  
Capital Gain 19.61% 88% B+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.61% 88% B+ 73% C
Trailing 5 Years  
Capital Gain -11.05% 6% D- 37% F
Dividend Return 2.38% 17% F 6% D-
Total Return -8.67% 6% D- 21% F
Average Annual (5 Year Horizon)  
Capital Gain -1.19% 11% F 26% F
Dividend Return -0.50% 11% F 18% F
Total Return 0.69% 61% D- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 30.11% 22% F 35% F
Risk Adjusted Return -1.67% 11% F 20% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.